ASPN · Aspen Aerogels, Inc.

The thesis

Aspen Aerogels' recovery case rests on electric-vehicle battery-barrier shipments and industrial demand returning the company to positive adjusted earnings, and the third-quarter 2026 report settles it. Management guided on 6 August 2026 to revenue of $65 million–$80 million and adjusted earnings before interest, taxes, depreciation and amortization (adjusted EBITDA) of $7 million–$15 million, after a second-quarter adjusted EBITDA loss of $6.6 million.

The shares closed at $5.63 on 8 October 2026, up from $5.22 on 25 September 2026 and 36.2% below the 52-week high of $8.82. The narrative is maturing: the recovery plan was restated in the 15 September 2026 investor deck, and the only company-related news item in the last 30 days is a 6 October 2026 posting of the transcript of the 6 August 2026 earnings call. The case weakens if the report falls below the $65 million revenue floor or shows an adjusted EBITDA loss.

Bullish and bearish views on Aspen Aerogels, Inc.

The bull case on Aspen Aerogels, Inc. (ASPN), in brief: Guidance implies a sharp step up. The bear case: Revenue is far below last year.

Bull case

• Guidance implies a sharp step up. Second-quarter 2026 revenue was $49.8 million, and the third-quarter guide is $65 million–$80 million (company release, 6 August 2026). A result inside the range would confirm the rebound; a result below $65 million would end it.
• Thermal Barrier revenue has turned. Second-quarter Thermal Barrier revenue was $29.5 million, up 81% from the first quarter (company release, 6 August 2026). Management credited stabilizing North American volumes and European programs.
• Europe adds a second customer base. On 6 August 2026 Aspen raised its 2026 European Thermal Barrier revenue outlook to $20 million–$30 million and announced a Jaguar Land Rover award with production expected in 2027. A cut to that outlook at the next report would weaken this point.
• Management has set a breakeven marker. The 15 September 2026 investor deck targeted about $175 million of annual revenue for adjusted EBITDA breakeven by year-end 2027, subject to production recovery. The third-quarter guide of positive adjusted EBITDA is the first test of that operating leverage.
• Insurance may offset incident costs. The chief financial officer said on 6 August 2026 that the company plans to submit insurance claims for East Providence incident costs. Recoveries would be a cash and earnings tailwind if they arrive.

Bear case

• Revenue is far below last year. Second-quarter revenue was $49.8 million versus $78.0 million a year earlier (company release, 6 August 2026). The third-quarter guide's low end is still below that prior-year level.
• One customer drives demand. The second-quarter Form 10-Q reports $23.7 million of Thermal Barrier revenue from one major U.S. automotive customer, versus $53.8 million a year earlier. Another drop in that customer's volume at the next filing would break the recovery.
• Settlement revenue flatters the quarter. The same 10-Q shows $4.9 million recognized from a customer settlement inside second-quarter Thermal Barrier revenue. Recurring shipments are the part that has to grow.
• Plant restoration runs into 2027. The 15 September 2026 deck targets full restoration of the East Providence plant in the first half of 2027. Any slip, or restart costs above plan, would pressure margins at the guided revenue level.
• Analyst targets sit near the share price. An aggregator summary retrieved 9 October 2026 shows seven analysts with an average 12-month target of $5.69, a high of $7.75 and a low of $4.00, and a consensus rating of Hold. The average target is 1.1% above the 8 October 2026 close.

Price setup

The adjusted close was $5.63 on 8 October 2026. The 14-day relative strength index (RSI) was 63.6, and the shares are up 8.7% over three months. The 52-week high is $8.82, 36.2% above the last close.

The 25 September 2026 close of $5.22 is the nearest reference low and the level used in this note's price case. The shares have since risen about 7.9% from it ahead of the third-quarter report. The next report date is unconfirmed, so the move into it is unanchored to a dated event.

Crowding evidence is thin. No Form 4 insider transactions or new SEC filings appear in the last 30 days, and no share issuance has been reported in that window. The one observable crowding factor is an earnings report within roughly four weeks, with an estimated date between 22 October 2026 and 6 November 2026.

Catalysts, next 30 days

• ~6 November 2026, est.: Possible third-quarter 2026 earnings release. Aspen has not confirmed a date in the sources checked; third-party calendars list dates from 22 October to 6 November 2026. The report tests the $65 million–$80 million revenue guide and the $7 million–$15 million adjusted EBITDA guide.
• After the report: The third-quarter Form 10-Q would show the share of Thermal Barrier revenue from the major U.S. automotive customer and any further settlement revenue.

Elapsed catalysts

• 30 September 2026 (passed): The third-quarter 2026 period closed. Results arrive with the report. (passed 20d ago)

What would change the view

The case breaks if third-quarter revenue lands below $65 million, if adjusted EBITDA is not positive, or if the 10-Q shows settlement revenue carrying the Thermal Barrier segment while customer shipments fall. A delay to the first-half 2027 East Providence restoration target would also weaken the operating case.

On price, a weekly close below $5.22, the 25 September 2026 close, would erase the rebound since late September. A report inside the guided ranges with Thermal Barrier shipments rising from the second quarter's $29.5 million would strengthen the case.

What it trades with

Aspen's results track electric-vehicle production schedules at a small number of automakers, mainly the major U.S. customer named in the 10-Q. Battery-pack supply chains and European vehicle programs, including the Jaguar Land Rover award, are the other direct drivers. Industrial insulation demand adds a separate source of revenue, but the filings reviewed give no segment split large enough to quantify it. No correlation figures against other stocks or indexes were measured for this note.